AZN Description — AstraZeneca Plc

AstraZeneca is a holding company. Through its subsidiaries, Co. is engaged in biopharmaceutical business focusing on the research, development and commercialization of prescription medicines. Co. focuses on disease areas that include Oncology; BioPharmaceuticals; Rare Disease; and Other Medicines and COVID-19. Key marketed products within the area of oncology include among other, Tagrisso (osimertinib) for lung cancer and Lynparza (olaparib) for ovarian cancer. Key marketed products within the area of Other Medicines and COVID-19 include among other, Synagis (palivizumab) for respiratory syncytial virus; and Evusheld (tixagevimab co-packaged with cilgavimab) for COVID-19.

Company Name: 
AstraZeneca Plc
Drugs & Pharmaceuticals
Number of ETFs Holding AZN: 
Total Market Value Held by ETFs: 
Total Market Capitalization: 
% of Market Cap. Held by ETFs: 
 ETF   AZN Weight   AZN Amount 
 QQQ   0.33%   $515,601,193         
 FVD   0.54%   $67,830,301         
 PPH   5.23%   $29,995,391         
 QQQM   0.33%   $21,208,669         
 TQQQ   0.17%   $20,886,787         
 QQEW   0.89%   $11,411,821         
 BIB   2.93%   $3,188,018         
 QQXT   1.41%   $2,134,525         
 IBBQ   3.64%   $755,878         
 SPGM   0.10%   $557,424         
List of all 14 ETFs holding AZN »
Quotes delayed 20 minutes

Email EnvelopeFree AZN Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Strong Buy (3.50 out of 4)
57th percentile
(ranked higher than approx. 57% of all stocks covered)

Analysts Forecast:
AZN Price Target

Based on data provided by Zacks Investment Research via

ETFs Holding AZN | AstraZeneca Plc | ETF Channel |

Copyright © 2010 - 2023, All Rights Reserved Nothing in ETF Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and ETF videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact ETF Channel; Meet Our Editorial Staff.